Literature DB >> 11076887

Hepatic iron overload in aceruloplasminaemia.

N E Hellman1, M Schaefer, S Gehrke, P Stegen, W J Hoffman, J D Gitlin, W Stremmel.   

Abstract

We report the case of a 52 year old male with diabetes mellitus and long standing evidence of hepatic iron excess. Initially considered to have haemochromatosis, this patient was reevaluated when hepatic iron stores were found to be unaffected by a prolonged course of weekly phlebotomy. The development of neurological disease prompted diagnostic consideration of aceruloplasminaemia, which we confirmed by demonstration of a novel frameshift mutation in the ceruloplasmin gene. Our inability to resolve the patient's iron overload by regular phlebotomy is consistent with recent animal studies indicating an essential role for ceruloplasmin in cellular iron efflux. Evaluation of this case underscores the clinical relevance of aceruloplasminaemia in the differential diagnosis of hepatic iron overload and provides insight into the pathogenetic mechanisms of hepatocellular iron storage and efflux.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076887      PMCID: PMC1728132          DOI: 10.1136/gut.47.6.858

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Aceruloplasminemia: a case report.

Authors:  Domenico Di Raimondo; Antonio Pinto; Antonino Tuttolomondo; Paola Fernandez; Clara Camaschella; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2008-04-12       Impact factor: 3.397

Review 2.  Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.

Authors:  Garth J S Cooper
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

3.  The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice.

Authors:  Juan Ma; Hui-Min Ma; Meng-Qi Shen; Yuan Yuan Wang; Yu-Xin Bao; Yong Liu; Ya Ke; Zhong-Ming Qian
Journal:  Front Cardiovasc Med       Date:  2022-05-20

4.  Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.

Authors:  R Mariani; C Arosio; S Pelucchi; M Grisoli; A Piga; P Trombini; A Piperno
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

5.  Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis.

Authors:  Hisao Hayashi; Ai Hattori; Yasuaki Tatsumi; Kazuhiko Hayashi; Yoshiaki Katano; Jun Ueyama; Shinya Wakusawa; Motoyoshi Yano; Hidemi Goto
Journal:  Med Mol Morphol       Date:  2013-01-22       Impact factor: 2.309

6.  Copper stabilizes the Menkes copper-transporting ATPase (Atp7a) protein expressed in rat intestinal epithelial cells.

Authors:  Liwei Xie; James F Collins
Journal:  Am J Physiol Cell Physiol       Date:  2012-11-21       Impact factor: 4.249

7.  Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.

Authors:  Armin Finkenstedt; Elisabeth Wolf; Elmar Höfner; Bethina Isasi Gasser; Sylvia Bösch; Rania Bakry; Marc Creus; Christian Kremser; Michael Schocke; Milan Theurl; Patrizia Moser; Melanie Schranz; Guenther Bonn; Werner Poewe; Wolfgang Vogel; Andreas R Janecke; Heinz Zoller
Journal:  J Hepatol       Date:  2010-08-04       Impact factor: 25.083

Review 8.  Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.

Authors:  Vassilena Iankova; Ivan Karin; Thomas Klopstock; Susanne A Schneider
Journal:  Front Neurol       Date:  2021-04-15       Impact factor: 4.003

9.  Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.

Authors:  Lena H P Vroegindeweij; Agnita J W Boon; J H Paul Wilson; Janneke G Langendonk
Journal:  Orphanet J Rare Dis       Date:  2020-04-25       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.